This is a prospective, multi-center, observational study of patients administered the Galleri® test as part of their medical care in a real-world setting. The purpose is to understand the performance of the test in clinical settings and the impact on patients and healthcare providers.
Patients who have been prescribed the Galleri test as part of medical care by their healthcare provider will have the opportunity to consent for participation into this data collection study.
The study will enroll approximately 35,000 participants, from participating integrated delivery networks and other health systems in North America. Participants will be actively followed for 5 years from the time of enrollment through data capture from electronic health records and periodic self-report questionnaires. Participants will also be passively followed through linkages to cancer registries and other administrative health databases.